Notable Movers (DRYS, GNK, ANTH, AXAS, ARNA)

DryShips Inc.(NASDAQ:DRYS) shares jumped 6.77% to $2.66. The 52 week trading range for the company is $1.75 - $3.84. The Paragon Report examines investing opportunities in the Shipping Industry and provides equity research on DryShips Inc. Shipping companies are rising as central banks around the globe have announced stimulus measures to try and improve their struggling economies. China, Europe and the U.S. have all announced stimulus plans in recent weeks which have boosted the international trade market.

Will DRYS Continue To Move Higher? Find Out Here

Genco Shipping & Trading Limited(NYSE:GNK) shares gained 5.61% to $4.33. The 52 week trading range for the company is $2.09 - $10.14. The shares of the company plunged 43% in the last one year. The company is engaged in the ocean transportation of drybulk cargoes worldwide through the ownership and operation of drybulk carrier vessels.

Anthera Pharmaceuticals Inc(NASDAQ:ANTH) shares fell 1.67% to $1.17. The company yesterday provided an update on regulatory discussions for the global development of blisibimod.  End of Phase 2 discussions with the US Food and Drug Administration (FDA) have been completed and will allow for the submission of Phase 3 protocols and the initiation of registration studies.  Earlier in 2012, Anthera received a written response from the European Medicines Agency (EMA) providing similar development feedback for the blisibimod program.

Abraxas Petroleum Corp.(NASDAQ:AXAS) stock climbed 5% to $2.41 on no official news. The 52 week trading range for the company is $1.86 - $4.45. The shares of the company declined 28% in the last one year. The company is an independent energy company primarily engaged in the acquisition, xploitation, development and production of oil and gas in the United States and Canada.

Get Latest News & Updates on AXAS Here

Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) shares fell 0.65% to $9.20 after Vivus announced the commercial launch of its weight-loss pill Qsymia Monday, beating rival Arena Pharmaceuticals to first reach the bulging waistbands of obese Americans. Arena and its marketing partner Eisai are expected to launch Belviq early next year.

The 52 week trading range for the company is $1.23 - $13.50. The shares of the company soared 467% in the last one year.